Literature DB >> 20515041

Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake.

Valentina Cauda1, Hanna Engelke, Anna Sauer, Delphine Arcizet, Christoph Bräuchle, Joachim Rädler, Thomas Bein.   

Abstract

We report on a one-step assembly route where supported lipid bilayers (SLB) are deposited on functionalized colloidal mesoporous silica (CMS) nanoparticles, resulting in a core-shell hybrid system (SLB@CMS). The supported membrane acts as an intact barrier against the escape of encapsulated dye molecules. These stable SLB@CMS particles loaded with the anticancer drug colchicine are readily taken up by cells and lead to the depolymerization of microtubules with remarkably enhanced efficiency as compared to the same dose of drug in solution.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515041     DOI: 10.1021/nl100991w

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  28 in total

1.  Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Authors:  Carlee E Ashley; Eric C Carnes; Katharine E Epler; David P Padilla; Genevieve K Phillips; Robert E Castillo; Dan C Wilkinson; Brian S Wilkinson; Cameron A Burgard; Robin M Kalinich; Jason L Townson; Bryce Chackerian; Cheryl L Willman; David S Peabody; Walker Wharton; C Jeffrey Brinker
Journal:  ACS Nano       Date:  2012-02-14       Impact factor: 15.881

Review 2.  Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.

Authors:  Kimberly S Butler; Paul N Durfee; Christophe Theron; Carlee E Ashley; Eric C Carnes; C Jeffrey Brinker
Journal:  Small       Date:  2016-01-18       Impact factor: 13.281

3.  Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.

Authors:  Xiangsheng Liu; Jinhong Jiang; Ryan Chan; Ying Ji; Jianqin Lu; Yu-Pei Liao; Michael Okene; Joshua Lin; Paulina Lin; Chong Hyun Chang; Xiang Wang; Ivanna Tang; Emily Zheng; Waveley Qiu; Zev A Wainberg; Andre E Nel; Huan Meng
Journal:  ACS Nano       Date:  2018-12-11       Impact factor: 15.881

Review 4.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

Review 5.  Membrane mimetic surface functionalization of nanoparticles: methods and applications.

Authors:  Jacob Weingart; Pratima Vabbilisetty; Xue-Long Sun
Journal:  Adv Colloid Interface Sci       Date:  2013-05-02       Impact factor: 12.984

Review 6.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

Review 7.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

8.  Liposome-coated mesoporous silica nanoparticles loaded with L-cysteine for photoelectrochemical immunoassay of aflatoxin B1.

Authors:  Youxiu Lin; Qian Zhou; Yongyi Zeng; Dianping Tang
Journal:  Mikrochim Acta       Date:  2018-06-02       Impact factor: 5.833

9.  Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer.

Authors:  Xiangsheng Liu; Allen Situ; Yanan Kang; Katie Rose Villabroza; Yupei Liao; Chong Hyun Chang; Timothy Donahue; Andre E Nel; Huan Meng
Journal:  ACS Nano       Date:  2016-02-09       Impact factor: 15.881

10.  Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Authors:  Katharine Epler; David Padilla; Genevieve Phillips; Peter Crowder; Robert Castillo; Dan Wilkinson; Brian Wilkinson; Cameron Burgard; Robin Kalinich; Jason Townson; Bryce Chackerian; Cheryl Willman; David Peabody; Walker Wharton; C Jeffrey Brinker; Carlee Ashley; Eric Carnes
Journal:  Adv Healthc Mater       Date:  2012-04-02       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.